• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4640408)   Today's Articles (208)   Subscriber (50364)
For: Tassakka ACMAR, Iskandar IW, Juniyazaki ABA, Zaenab S, Alam JF, Rasyid H, Kasmiati K, Sinurat E, Dwiany FM, Martien R, Moore AM. Green algae Caulerpa racemosa compounds as antiviral candidates for SARS-CoV-2: In silico study. Narra J 2023;3:e179. [PMID: 38454975 PMCID: PMC10919702 DOI: 10.52225/narra.v3i2.179] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/25/2023] [Accepted: 07/24/2023] [Indexed: 03/09/2024]
Number Cited by Other Article(s)
1
Herdiansyah MA, Rizaldy R, Alifiansyah MRT, Fetty AJT, Anggraini D, Agustina N, Alfian FR, Setianingsih PNM, Elfianah V, Aulia HS, Putra JERP, Ansori ANM, Kharisma VD, Jakhmola V, Purnobasuki H, Pratiwi IA, Rebezov M, Shmeleva S, Bonkalo T, Kovalchuk DF, Zainul R. Molecular interaction analysis of ferulic acid (4-hydroxy-3-methoxycinnamic acid) as main bioactive compound from palm oil waste against MCF-7 receptors: An in silico study. NARRA J 2024;4:e775. [PMID: 39280296 PMCID: PMC11391962 DOI: 10.52225/narra.v4i2.775] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/29/2024] [Accepted: 07/14/2024] [Indexed: 09/18/2024]
2
Jarab AS, Abu Heshmeh SR, Al Meslamani AZ. Biosimilars as antivirals: opportunities and challenges. Expert Rev Anti Infect Ther 2024;22:273-275. [PMID: 38288681 DOI: 10.1080/14787210.2024.2313064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2023] [Accepted: 01/29/2024] [Indexed: 02/02/2024]
3
Arman M, Alam S, Maruf RA, Shams Z, Islam MN. Molecular modeling of some commercially available antiviral drugs and their derivatives against SARS-CoV-2 infection. NARRA J 2024;4:e319. [PMID: 38798846 PMCID: PMC11125382 DOI: 10.52225/narra.v4i1.319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/13/2023] [Accepted: 02/07/2024] [Indexed: 05/29/2024]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA